Tripos Announces Presentation and Web Cast From The Tucker Anthony Sutro Healthcare Conference

Apr 02, 2001, 01:00 ET from Tripos, Inc.

    ST. LOUIS, April 2 /PRNewswire/ -- Tripos, Inc. (Nasdaq:   TRPS) announced
 today that its presentation at the Tucker Anthony Sutro Healthcare Conference
 2001, to be held April 4 - 6, 2001, will be web cast live (audio) and may be
 accessed at http://www.tripos.com.
     Tripos' President and CEO, John McAlister, will provide an overview of the
 company's technologies, product candidates and business strategy. The
 presentation and live audio web cast will be given at 2:25 p.m. PDT
 (11:25 a.m. EDT), on Thursday, April 5, 2001, from the conference center in
 Laguna Niguel, California. The web cast will be archived for 21 day.
 
     About Tripos, Inc.
     Tripos is a leading provider of discovery research software and services
 to pharmaceutical, biotechnology, and other life science companies worldwide.
 The company's products and services aim to greatly accelerate the discovery of
 new drugs while reducing the costs associated with the drug discovery process.
 Tripos products include proprietary discovery software tools to manage,
 analyze and share biological and chemical information; systems integration and
 software consulting services; diverse chemical libraries; and contract
 research for the discovery, synthesis, characterization and optimization of
 new chemical compounds that are active in biological systems.  This press
 release and further information about Tripos can be found on the World Wide
 Web at http://www.tripos.com.
 
     This press release may contain certain statements that are forward-looking
 and involve risks and uncertainties. Words such as "expects," "anticipates,"
 "projects," "estimates," "intends," "plans," "believes," variations of such
 words and similar expressions are intended to identify such forward-looking
 statements. These statements are based on current expectations and projections
 made by management and are not guarantees of future performance. Therefore,
 actual events, outcomes and results may differ materially from what is
 expressed or forecast in such forward-looking statements. Tripos has
 identified certain factors that could cause actual results to differ
 materially from the forward-looking statements in its Annual Report on Form
 10-K, its Quarterly Reports on Form 10-Q, and its Current Report on Form 8-K.
 Tripos undertakes no obligation to update any forward-looking statements
 contained herein.
 
      Contacts:
      Tripos, Inc.                            Noonan/Russo Communications, Inc.
      Colleen A. Martin                       Prateek Patnaik (Media) ext. 273
      Chief Financial Officer                 (212) 696-4455
      (314) 647-1099 or (800) 323-2960
 
 

SOURCE Tripos, Inc.
    ST. LOUIS, April 2 /PRNewswire/ -- Tripos, Inc. (Nasdaq:   TRPS) announced
 today that its presentation at the Tucker Anthony Sutro Healthcare Conference
 2001, to be held April 4 - 6, 2001, will be web cast live (audio) and may be
 accessed at http://www.tripos.com.
     Tripos' President and CEO, John McAlister, will provide an overview of the
 company's technologies, product candidates and business strategy. The
 presentation and live audio web cast will be given at 2:25 p.m. PDT
 (11:25 a.m. EDT), on Thursday, April 5, 2001, from the conference center in
 Laguna Niguel, California. The web cast will be archived for 21 day.
 
     About Tripos, Inc.
     Tripos is a leading provider of discovery research software and services
 to pharmaceutical, biotechnology, and other life science companies worldwide.
 The company's products and services aim to greatly accelerate the discovery of
 new drugs while reducing the costs associated with the drug discovery process.
 Tripos products include proprietary discovery software tools to manage,
 analyze and share biological and chemical information; systems integration and
 software consulting services; diverse chemical libraries; and contract
 research for the discovery, synthesis, characterization and optimization of
 new chemical compounds that are active in biological systems.  This press
 release and further information about Tripos can be found on the World Wide
 Web at http://www.tripos.com.
 
     This press release may contain certain statements that are forward-looking
 and involve risks and uncertainties. Words such as "expects," "anticipates,"
 "projects," "estimates," "intends," "plans," "believes," variations of such
 words and similar expressions are intended to identify such forward-looking
 statements. These statements are based on current expectations and projections
 made by management and are not guarantees of future performance. Therefore,
 actual events, outcomes and results may differ materially from what is
 expressed or forecast in such forward-looking statements. Tripos has
 identified certain factors that could cause actual results to differ
 materially from the forward-looking statements in its Annual Report on Form
 10-K, its Quarterly Reports on Form 10-Q, and its Current Report on Form 8-K.
 Tripos undertakes no obligation to update any forward-looking statements
 contained herein.
 
      Contacts:
      Tripos, Inc.                            Noonan/Russo Communications, Inc.
      Colleen A. Martin                       Prateek Patnaik (Media) ext. 273
      Chief Financial Officer                 (212) 696-4455
      (314) 647-1099 or (800) 323-2960
 
 SOURCE  Tripos, Inc.